(Q43982012)

English

Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experience

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukemia: a single institution's experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

childhood acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Abbott BL

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Rubnitz JE

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Tong X

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Srivastava DK

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Pui CH

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Ribeiro RC

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Razzouk BI

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

2090-2096

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Preventive central nervous system irradiation in children with acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

Current Pharmacological Treatment Approaches to Central Nervous System Leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

The clinical pharmacokinetics of cladribine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regimen including etoposide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

The Analysis of Failure Times in the Presence of Competing Risks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

[Neuropsychological sequelae in children with AML treated with or without prophylactic CNS-irradiation].

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

21 January 2018

CNS involvement in acute myelomonoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

7 January 2021

based on heuristic

inferred from DOI database lookup

Toward optimal central nervous system-directed treatment in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

7 January 2021

based on heuristic

inferred from DOI database lookup

A direct bone marrow chromosome technique for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged intrathecal chemotherapy replacing cranial irradiation in high-risk acute lymphatic leukaemia: long-term follow up with cerebral computed tomography scans and endocrinological studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

7 January 2021

based on heuristic

inferred from DOI database lookup

Late effects of treatment in survivors of childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403131

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403131

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43982012&oldid=2206371078"